BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 29764424)

  • 1. Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation.
    Liu X; Liang Y; Song R; Yang G; Han J; Lan Y; Pan S; Zhu M; Liu Y; Wang Y; Meng F; Cui Y; Wang J; Zhang B; Song X; Lu Z; Zheng T; Liu L
    Mol Cancer; 2018 May; 17(1):90. PubMed ID: 29764424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEAT1 promotes cell proliferation and invasion in hepatocellular carcinoma by negative regulating miR-613 expression.
    Wang Z; Zou Q; Song M; Chen J
    Biomed Pharmacother; 2017 Oct; 94():612-618. PubMed ID: 28783584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3.
    Zhang XN; Zhou J; Lu XJ
    J Cell Physiol; 2018 Sep; 233(9):6733-6741. PubMed ID: 29219178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of long non‑coding RNA NEAT1 inhibits hepatocellular carcinoma progression by downregulating SMO by sponging microRNA‑503.
    Sun C; Xiao T; Xiao Y; Li Y
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33398379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA NEAT1 regulates the proliferation and migration of hepatocellular carcinoma cells by acting as a miR‑320a molecular sponge and targeting L antigen family member 3.
    Zhang Y; Huang C; Zhu Z; Hou Y; Huang S; Sun C; Tang Y; Zhang Z; Wang L; Chen H; Ju W; Qiao X; Chen M
    Int J Oncol; 2020 Oct; 57(4):1001-1012. PubMed ID: 32945386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEAT1 upregulates TGF-β1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p.
    Tu J; Zhao Z; Xu M; Lu X; Chang L; Ji J
    J Cell Physiol; 2018 Nov; 233(11):8578-8587. PubMed ID: 29797561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of lncRNA NEAT1_2 radiosensitizes hepatocellular carcinoma cells through regulation of miR-101-3p/WEE1 axis.
    Chen X; Zhang N
    Cell Biol Int; 2019 Jan; 43(1):44-55. PubMed ID: 30488993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
    Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
    Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
    Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
    Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
    J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J; Li T; Han X; Yuan H
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway.
    Li X; Cheng T; He Y; Zhou S; Wang Y; Zhang K; Yu P
    Life Sci; 2019 Sep; 232():116602. PubMed ID: 31251997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
    Liu Z; Ouyang G; Lu W; Zhang H
    Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
    Fan JC; Zeng F; Le YG; Xin L
    J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATGL promotes the proliferation of hepatocellular carcinoma cells via the p-AKT signaling pathway.
    Liu M; Yu X; Lin L; Deng J; Wang K; Xia Y; Tang X; Hong H
    J Biochem Mol Toxicol; 2019 Nov; 33(11):e22391. PubMed ID: 31476254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
    Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
    J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1.
    Pan G; Zhang J; You F; Cui T; Luo P; Wang S; Li X; Yuan Q
    Bioengineered; 2022 Jan; 13(1):1346-1358. PubMed ID: 34983308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.